Impact of Donor MHC Class I or Class II Antigen Deficiency on First‐ and Second‐set Rejection of Mouse Heart or Liver Allografts

S Qian,F Fu,Y Li,L Lu,AS Rao,TE Starzl,AW Thomson,JJ Fung

DOI: https://doi.org/10.1046/j.1365-2567.1996.d01-633.x

1996-01-01

Immunology

Abstract:The influence of donor major histocompatibility complex (MHC) class I‐ or class II‐deficiency on the initiation of first‐ and second‐set rejection of mouse heart and liver allografts was examined. C3H (H‐2k) mice received heterotopic cardiac or orthotopic liver grafts from unmodified B10 (H‐2b), B6 (H‐2b), b2m (H‐2b; class I deficient) or AB0 (H‐2b; class II deficient) donors. Organ survival was also investigated in C3H recipients that had been presensitized by a normal B10 skin graft 2–3 weeks before heart or liver transplantation. The absence of cell surface MHC class I or class II resulted in significant prolongation of primary cardiac allograft survival. Three of seven (43%) MHC class I‐deficient, and two of five (40%) class II‐deficient heart grafts were accepted indefinitely (survival time >100 days). Thus both MHC class I and class II molecules appear to be important for the elicitation of first‐set rejection in the heart allograft model. All liver allografts survived >100 days in normal recipients. In C3H recipients that had been presensitized by a B10 skin graft, however, both heart and liver grafts from AB0 (class II deficient) donors underwent accelerated rejection (median survival time [MST] 3 and 4 days, respectively). In contrast, liver grafts from class I‐deficient mice (b2m) were still accepted indefinitely by B10 skin‐presensitized C3H recipients, whereas class I‐deficient hearts survived significantly longer than those from class II‐deficient or normal donors. These data demonstrate that the expression of donor MHC class I, and not class II is crucial in initiating second‐set organ allograft rejection. In vitro monitoring revealed that at the time of organ transplant, both splenocytes and serum of the skin‐presensitized animals displayed high cytotoxicity against AB0 (class II‐deficient) but not against b2m (class I‐deficient) targets.